Iktos And Zealand Pharma Will Work Together To Develop AI Technology For The Design Of Peptide Drugs
Today, Zealand Pharma A/S, a biotechnology company transforming lives with cutting-edge peptide-based medicines, and Iktos, a company specializing in artificial intelligence for new drug design, announced a research collaboration to co-develop generative and predictive AI technologies for peptide drug design. With its deep data-driven chemical structure creation technology, Iktos' AI technology revolutionizes the drug discovery process. With the help...